Sharp Therapeutics Corp. (TSXV:SHRX)

Sharp Therapeutics Statistics

Total Valuation

TSXV:SHRX has a market cap or net worth of CAD 52.21 million. The enterprise value is 72.45 million.

Market Cap	52.21M
Enterprise Value	72.45M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

TSXV:SHRX has 28.22 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	28.22M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.63%
Owned by Institutions (%)	0.75%
Float	15.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-2.63
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.77
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-24.12

Financial Position

The company has a current ratio of 0.02

Current Ratio	0.02
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-6.85
Interest Coverage	-16.66

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	21.78%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	46.91
Average Volume (20 Days)	2,976

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.94M
Pretax Income	-6.73M
Net Income	-6.73M
EBITDA	-3.97M
EBIT	-3.94M
Earnings Per Share (EPS)	-48.30

Balance Sheet

The company has 320,094 in cash and 20.57 million in debt, giving a net cash position of -20.25 million or -0.72 per share.

Cash & Cash Equivalents	320,094
Total Debt	20.57M
Net Cash	-20.25M
Net Cash Per Share	-0.72
Equity (Book Value)	-19.86M
Book Value Per Share	-14.26
Working Capital	-19.57M

Cash Flow

In the last 12 months, operating cash flow was -2.98 million and capital expenditures -19,829, giving a free cash flow of -3.00 million.

Operating Cash Flow	-2.98M
Capital Expenditures	-19,829
Free Cash Flow	-3.00M
FCF Per Share	-0.11

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSXV:SHRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-12.88%
FCF Yield	-5.75%

Stock Splits

The last stock split was on January 27, 2025. It was a reverse split with a ratio of 0.1.

Last Split Date	Jan 27, 2025
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a